Literature DB >> 3976321

Epidural morphine for postoperative pain: experience with 1085 patients.

R Stenseth, O Sellevold, H Breivik.   

Abstract

A prospective study of the effect and side-effects of epidural morphine for pain relief in 1085 patients after thoracic, abdominal, urologic, or orthopaedic surgery was performed. Morphine chloride was diluted in saline or bupivacaine and administered through an epidural catheter placed at a segmental level appropriate for the type of surgery. The initial dose was 4 or 6 mg morphine and supplementary doses were given when needed to obtain complete freedom from pain during deep breathing or nursing care. The total dose of epidural morphine from end of surgery until the next morning varied from 4 to 18 mg. 97% of hip arthroplasty patients, 91% of prostatectomy patients and thoracotomy patients, 90% of patients after major lower extremity surgery and 88% of patients after laparotomy were completely satisfied with the postoperative course. For hip arthroplasty and major extremity surgery, an initial dose of 4 mg of epidural morphine was as effective as 6 mg. After prostatectomy, laparotomy, and thoracotomy, an initial dose of 6 mg gave significantly better effect than 4 mg. Pruritus occurred in 11%, nausea or vomiting in 34%, and respiratory depression in 0.9% of the total patient population. Urinary retention occurred in 42% of patients not having urinary catheters in place. Postoperative nausea or vomiting was more frequent in women than in men (P less than 0.001). There was a higher incidence of nausea or vomiting in men experiencing pain than in men who were completely pain-free after abdominal surgery (P less than 0.001). Respiratory depression was rare and occurred as a gradually decreasing respiratory rate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3976321     DOI: 10.1111/j.1399-6576.1985.tb02176.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  25 in total

1.  Optimum dose of epidural morphine for postsurgical analgesia.

Authors:  G Ochi; C Yamane; T Arai
Journal:  J Anesth       Date:  1990-01       Impact factor: 2.078

2.  Interabdominal analgesia in pain management after cholecystectomy: A preliminary report.

Authors:  H Iwama; T Suzuki; S Hirata; K Kawamae; Y Akama; C Tase; A Okuaki
Journal:  J Anesth       Date:  1994-09       Impact factor: 2.078

Review 3.  Neuraxial morphine and respiratory depression: finding the right balance.

Authors:  Pervez Sultan; Maria Cristina Gutierrez; Brendan Carvalho
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

4.  Effects of morphine metabolites on micturition in normal, unanaesthetized rats.

Authors:  Y Igawa; D Westerling; A Mattiasson; K E Andersson
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  Combined spinal epidural block versus spinal and epidural block for orthopaedic surgery.

Authors:  B Holmström; K Laugaland; N Rawal; S Hallberg
Journal:  Can J Anaesth       Date:  1993-07       Impact factor: 5.063

Review 6.  Spinal opioid analgesia. A critical update.

Authors:  L L Gustafsson; Z Wiesenfeld-Hallin
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

7.  Epidural morphine for analgesia after caesarean section: a report of 4880 patients.

Authors:  J G Fuller; G H McMorland; M J Douglas; L Palmer
Journal:  Can J Anaesth       Date:  1990-09       Impact factor: 5.063

8.  A comparison of lumbar epidural and intravenous fentanyl infusions for post-thoracotomy analgesia.

Authors:  A D Baxter; S Laganière; B Samson; J Stewart; K Hull; L Goernert
Journal:  Can J Anaesth       Date:  1994-03       Impact factor: 5.063

9.  Postoperative pain management and acute pain service activity in Canada.

Authors:  D L Zimmermann; J Stewart
Journal:  Can J Anaesth       Date:  1993-06       Impact factor: 5.063

10.  Epidural morphine reduces halothane MAC in humans.

Authors:  I M Schwieger; C E Klopfenstein; A Forster
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.